Predict your next investment

Private Equity

See what CB Insights has to offer

Investments

1

Portfolio Exits

1

Funds

2

About Xiangjiang Liyuan

A private equity firm launched by Sinopharm Group, Hunan Xiangtou Group, and China Merchants Securities.

Xiangjiang Liyuan Headquarter Location

Changsha, Hunan,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Xiangjiang Liyuan Investments

1 Investments

Xiangjiang Liyuan has made 1 investments. Their latest investment was in Nucien as part of their Growth Equity on August 8, 2016.

CBI Logo

Xiangjiang Liyuan Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/3/2016

Growth Equity

Nucien

$19.77M

Yes

1

Date

8/3/2016

Round

Growth Equity

Company

Nucien

Amount

$19.77M

New?

Yes

Co-Investors

Sources

1

Xiangjiang Liyuan Portfolio Exits

1 Portfolio Exit

Xiangjiang Liyuan has 1 portfolio exit. Their latest portfolio exit was Nucien on March 26, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/26/2020

IPO

1

Date

3/26/2020

Exit

IPO

Companies

Valuation

Acquirer

Sources

1

Xiangjiang Liyuan Fund History

2 Fund Histories

Xiangjiang Liyuan has 2 funds, including Hunan Tianjian Xiangjiang Healthcare Investment Fund I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

7/20/2014

Hunan Tianjian Xiangjiang Healthcare Investment Fund I

Multi-Stage Venture Capital

$1.61M

1

1/26/2014

Changsha Xiangte Investment Enterprise LP

Subscribe to see more

$99M

10

Closing Date

7/20/2014

1/26/2014

Fund

Hunan Tianjian Xiangjiang Healthcare Investment Fund I

Changsha Xiangte Investment Enterprise LP

Fund Type

Multi-Stage Venture Capital

Subscribe to see more

Status

Amount

$1.61M

$99M

Sources

1

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.